Neuropharmacology 111 , 160168 (2016)
The Glutathione System: A New Drug Target in Neuroimmune Disorders
of the plasma concentrations in the three cohorts (excluding poorly/non-compliant patients), we computed that the sample size in the smallest cohort ( n =77, Leb) would already provide 92.9% power in the analyses
At Real Peptides , every vial is produced in the USA, lab-tested for 99% purity, and shipped cold for research integrity
But as demand grows, the conversation is expanding to address the question of scale: How can personalized medicine be delivered to every patient and provider who needs it without compromising quality, safety, or consistency
If you aren't sleeping, you aren't producing